Khera et al listed nonmalignant late effects following hematopoietic cell transplant (HCT). These can result in significant disability for the patient. The authors are from Fred Hutchinson Cancer Research Center in Seattle, Washington.
Number of late effects listed (14):
avascular necrosis
joint replacement
osteoporosis
thyroid disease
diabetes mellitus
adrenal insufficiency
cerebrovascular disease
coronary artery disease
deep vein thrombosis (not intravascular catheter associated in study)
obstructive or restrictive lung disease
dialysis (renal insufficiency)
organ transplantation
suicide or suicide attempt
iron overload
Others that could be added:
(1) anxiety and/or depression
(2) infection
(3) nutritional problems
Specifically not included in the study: chronic graft-versus-host disease (GVHD)
To read more or access our algorithms and calculators, please log in or register.
